Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-18 8:19 pm Unchanged | 13G | BioXcel Therapeutics Inc. BTAI | Oaktree Capital Group Holdings GP LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-12-18 5:20 pm Unchanged | 13G | BioXcel Therapeutics Inc. BTAI | Qatar Investment Authority | 0 0.000% | 0 (Unchanged) | View |
| 2024-09-10 10:47 am Sale | 13G | BioXcel Therapeutics Inc. BTAI | FMR LLC | 1,075,324 2.639% | -1,443,240 (-57.30%) | View |
| 2024-06-06 8:29 pm Sale | 13D | BioXcel Therapeutics Inc. BTAI | BioXcel LLC | 8,830,622 23.500% | -674,023 (-7.09%) | View |
| 2024-02-09 08:35 am Sale | 13G | BioXcel Therapeutics Inc. BTAI | FMR LLC | 2,518,564 8.603% | -182,163 (-6.74%) | View |
| 2024-02-07 07:27 am Sale | 13G | BioXcel Therapeutics Inc. BTAI | ADAGE CAPITAL PARTNERS GP L.L.C. | 465,381 1.550% | -1,083,210 (-69.95%) | View |
| 2023-10-19 4:48 pm Unchanged | 13G | BioXcel Therapeutics Inc. BTAI | BioXcel Holdings Inc. | 8,901,750 30.100% | 0 (Unchanged) | View |
| 2023-10-13 4:01 pm Sale | 13G | BioXcel Therapeutics Inc. BTAI | FMR LLC | 2,700,727 9.227% | -1,502,709 (-35.75%) | View |
| 2023-10-10 09:09 am Purchase | 13G | BioXcel Therapeutics Inc. BTAI | FIL Ltd | 2,700,727 9.227% | 2,700,727 (New Position) | View |
| 2023-09-28 5:00 pm Sale | 13D | BioXcel Therapeutics Inc. BTAI | BioXcel LLC | 9,504,645 32.500% | -253,160 (-2.59%) | View |
| 2023-04-04 06:00 am Sale | 13G | BioXcel Therapeutics Inc. BTAI | BioXcel Holdings Inc. | 8,901,750 30.300% | -550,323 (-5.82%) | View |
| 2023-02-14 4:36 pm Purchase | 13G | BioXcel Therapeutics Inc. BTAI | BioXcel Holdings Inc. | 9,452,073 32.700% | 134,022 (+1.44%) | View |
| 2023-02-13 7:09 pm Sale | 13G | BioXcel Therapeutics Inc. BTAI | ALLIANCEBERNSTEIN L.P. | 39,538 0.100% | -1,450,033 (-97.35%) | View |
| 2023-02-09 09:02 am Sale | 13G | BioXcel Therapeutics Inc. BTAI | BlackRock Inc. BLK | 1,312,403 4.700% | -150,519 (-10.29%) | View |
| 2023-02-09 08:23 am Purchase | 13G | BioXcel Therapeutics Inc. BTAI | FMR LLC | 4,203,436 14.999% | 6,387 (+0.15%) | View |
| 2023-02-03 12:10 pm Purchase | 13G | BioXcel Therapeutics Inc. BTAI | BlackRock Inc. BLK | 1,462,922 5.200% | 1,462,922 (New Position) | View |
| 2023-02-02 4:45 pm Purchase | 13G | BioXcel Therapeutics Inc. BTAI | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,548,591 5.530% | 1,548,591 (New Position) | View |
| 2022-02-14 4:57 pm Sale | 13G | BioXcel Therapeutics Inc. BTAI | BioXcel Holdings Inc. | 9,318,051 32.400% | -316,950 (-3.29%) | View |
| 2022-02-14 4:02 pm Purchase | 13G | BioXcel Therapeutics Inc. BTAI | ALLIANCEBERNSTEIN L.P. | 1,489,571 5.400% | 1,489,571 (New Position) | View |
| 2022-02-09 12:01 pm Sale | 13G | BioXcel Therapeutics Inc. BTAI | STATE STREET CORP STT | 1,345,096 4.810% | -328,900 (-19.65%) | View |